Loading...

Biotin anti-mouse CD11c Antibody Biotin anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
a-N418_A_Biotin_Pos_071006
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and biotinylated N418 (top) or biotinylated Armenian hamster IgG isotype control (bottom), followed by Sav-PE
  • a-N418_A_Biotin_Pos_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and biotinylated N418 (top) or biotinylated Armenian hamster IgG isotype control (bottom), followed by Sav-PE
  • b-N418_B_Biotin_Neg_071006
  • c-N418_Biotin_CD11c_Antibody_3_012621
    Frozen mouse spleen sections. Endogenous biotin blocking applied prior to incubation of primary antibody anti‐mouse CD11c biotin followed by secondary detection with Alexa Fluor® 555 streptavidin. Images were acquired with an automated widefield microscope (Nikon Eclipse Ti) and a CCD camera (QImaging Retiga 2000R). Images provided by Ann Haberman and Tingting Zhang, Yale University.
Compare all formats
Cat # Size Price Quantity Check Availability Save
117304 500 µg SEK2218
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117303 50 µg SEK647
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
IHC-F - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  2. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  3. Kellermayer Z, et al. 2019. J Immunol. 202:1833. PubMed
  4. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  5. Chanda MK, et al. 2022. J Immunol Methods. 506:113290. PubMed
  6. Campisi L, et al. 2022. Nature. 606:945. PubMed
  7. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  8. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  9. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  10. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  11. Khaw YM, et al. 2023. EMBO Rep. 24:e54228. PubMed
  12. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  13. Wu Q, et al. 2023. Cell Rep. 42:112057. PubMed
  14. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  15. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  16. Liu S, et al. 2020. Neuron. S0896-6273(20)30532-8.. PubMed
  17. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  18. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  19. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  20. Zhou L, et al. 2021. Cell Mol Immunol. 18:698. PubMed
  21. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  22. Hu Z, et al. 2015. J Exp Med. 101084/jm20150178. PubMed
  23. Palumbo R, et al. 2012. J Control Release. 159:232. PubMed
  24. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  25. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  26. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  27. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  28. Mori T, et al. 2014. J Immunol. 193:1728. PubMed
  29. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  30. Stone MB et al. 2017. eLife. 6 pii: e19891. PubMed
  31. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  32. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  33. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  34. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  35. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  36. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  37. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  38. Khaw YM, et al. 2020. J Neuroinflammation. 17:49. PubMed
  39. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  40. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  41. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  42. Köchl R, et al. 2020. Elife. 9:00. PubMed
  43. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  44. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  45. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  46. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  47. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  48. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  49. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  50. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  51. Yang Z et al. 2016. eLife. 5 pii: e21238. PubMed
  52. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  53. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  54. Lei G, et al. 2015. Infect Immun . 83:572. PubMed
  55. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  56. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  57. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  58. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  59. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  60. Jawhara S, et al. 2012. J Immunol. 189:2468. PubMed
  61. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  62. Cheng Q, et al. 2014. J Immunol. 192:3686. PubMed
  63. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  64. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  65. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  66. Baptista A, et al. 2014. Elife. 3:4433. PubMed
  67. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  68. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  69. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  70. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  71. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  72. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  73. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  74. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  75. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  76. Hu G, et al. 2018. Immunity. 48:227. PubMed
  77. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  78. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  79. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  80. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  81. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  82. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  83. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  84. Zhu J et al. 2017. Cell stem cell. 20(3):374-384 . PubMed
  85. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  86. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  87. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  88. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  89. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  90. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  91. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  92. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  93. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  94. Kellermayer Z, et al. 2019. J Immunol. 202:1833. PubMed
  95. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  96. Chanda MK, et al. 2022. J Immunol Methods. 506:113290. PubMed
  97. Campisi L, et al. 2022. Nature. 606:945. PubMed
  98. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  99. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  100. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  101. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  102. Khaw YM, et al. 2023. EMBO Rep. 24:e54228. PubMed
  103. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  104. Wu Q, et al. 2023. Cell Rep. 42:112057. PubMed
  105. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  106. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  107. Liu S, et al. 2020. Neuron. S0896-6273(20)30532-8.. PubMed
  108. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  109. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  110. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  111. Zhou L, et al. 2021. Cell Mol Immunol. 18:698. PubMed
  112. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  113. Hu Z, et al. 2015. J Exp Med. 101084/jm20150178. PubMed
  114. Palumbo R, et al. 2012. J Control Release. 159:232. PubMed
  115. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  116. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  117. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  118. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  119. Mori T, et al. 2014. J Immunol. 193:1728. PubMed
  120. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  121. Stone MB et al. 2017. eLife. 6 pii: e19891. PubMed
  122. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  123. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  124. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  125. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  126. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  127. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  128. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  129. Khaw YM, et al. 2020. J Neuroinflammation. 17:49. PubMed
  130. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  131. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  132. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  133. Köchl R, et al. 2020. Elife. 9:00. PubMed
  134. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  135. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  136. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  137. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  138. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  139. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  140. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  141. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  142. Yang Z et al. 2016. eLife. 5 pii: e21238. PubMed
  143. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  144. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  145. Lei G, et al. 2015. Infect Immun . 83:572. PubMed
  146. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  147. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  148. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  149. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  150. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  151. Jawhara S, et al. 2012. J Immunol. 189:2468. PubMed
  152. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  153. Cheng Q, et al. 2014. J Immunol. 192:3686. PubMed
  154. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  155. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  156. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  157. Baptista A, et al. 2014. Elife. 3:4433. PubMed
  158. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  159. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  160. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  161. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  162. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  163. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  164. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  165. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  166. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  167. Hu G, et al. 2018. Immunity. 48:227. PubMed
  168. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  169. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  170. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  171. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  172. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  173. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  174. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  175. Zhu J et al. 2017. Cell stem cell. 20(3):374-384 . PubMed
  176. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  177. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  178. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  179. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  180. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  181. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  182. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
RRID
AB_313773 (BioLegend Cat. No. 117304)
AB_313772 (BioLegend Cat. No. 117303)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
PE/Fire™ 640 anti-mouse CD11c Antibody N418 FC
APC/Fire™ 810 anti-mouse CD11c Antibody N418 FC
Spark PLUS B550™ anti-mouse CD11c N418 FC
Spark PLUS V475™ anti-mouse CD11c Antibody N418 FC
Spark YG™ 581 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark YG™ 593 anti-mouse CD11c (Flexi-Fluor™) Antibody N418 FC
Go To Top Version: 4    Revision Date: 01-26-2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
a-N418_A_Biotin_Pos_071006
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and biotinylated N418 (top) or biotinylated Armenian hamster IgG isotype control (bottom), followed by Sav-PE
  • a-N418_A_Biotin_Pos_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and biotinylated N418 (top) or biotinylated Armenian hamster IgG isotype control (bottom), followed by Sav-PE
  • b-N418_B_Biotin_Neg_071006
  • c-N418_Biotin_CD11c_Antibody_3_012621
    Frozen mouse spleen sections. Endogenous biotin blocking applied prior to incubation of primary antibody anti‐mouse CD11c biotin followed by secondary detection with Alexa Fluor® 555 streptavidin. Images were acquired with an automated widefield microscope (Nikon Eclipse Ti) and a CCD camera (QImaging Retiga 2000R). Images provided by Ann Haberman and Tingting Zhang, Yale University.
Compare all formats
Cat # Size Price Quantity Check Availability Save
117304 500 µg SEK2218
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117303 50 µg SEK647
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
IHC-F - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  2. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  3. Kellermayer Z, et al. 2019. J Immunol. 202:1833. PubMed
  4. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  5. Chanda MK, et al. 2022. J Immunol Methods. 506:113290. PubMed
  6. Campisi L, et al. 2022. Nature. 606:945. PubMed
  7. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  8. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  9. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  10. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  11. Khaw YM, et al. 2023. EMBO Rep. 24:e54228. PubMed
  12. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  13. Wu Q, et al. 2023. Cell Rep. 42:112057. PubMed
  14. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  15. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  16. Liu S, et al. 2020. Neuron. S0896-6273(20)30532-8.. PubMed
  17. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  18. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  19. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  20. Zhou L, et al. 2021. Cell Mol Immunol. 18:698. PubMed
  21. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  22. Hu Z, et al. 2015. J Exp Med. 101084/jm20150178. PubMed
  23. Palumbo R, et al. 2012. J Control Release. 159:232. PubMed
  24. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  25. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  26. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  27. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  28. Mori T, et al. 2014. J Immunol. 193:1728. PubMed
  29. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  30. Stone MB et al. 2017. eLife. 6 pii: e19891. PubMed
  31. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  32. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  33. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  34. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  35. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  36. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  37. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  38. Khaw YM, et al. 2020. J Neuroinflammation. 17:49. PubMed
  39. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  40. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  41. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  42. Köchl R, et al. 2020. Elife. 9:00. PubMed
  43. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  44. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  45. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  46. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  47. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  48. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  49. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  50. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  51. Yang Z et al. 2016. eLife. 5 pii: e21238. PubMed
  52. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  53. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  54. Lei G, et al. 2015. Infect Immun . 83:572. PubMed
  55. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  56. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  57. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  58. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  59. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  60. Jawhara S, et al. 2012. J Immunol. 189:2468. PubMed
  61. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  62. Cheng Q, et al. 2014. J Immunol. 192:3686. PubMed
  63. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  64. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  65. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  66. Baptista A, et al. 2014. Elife. 3:4433. PubMed
  67. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  68. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  69. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  70. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  71. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  72. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  73. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  74. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  75. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  76. Hu G, et al. 2018. Immunity. 48:227. PubMed
  77. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  78. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  79. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  80. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  81. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  82. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  83. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  84. Zhu J et al. 2017. Cell stem cell. 20(3):374-384 . PubMed
  85. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  86. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  87. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  88. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  89. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  90. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  91. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  92. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  93. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  94. Kellermayer Z, et al. 2019. J Immunol. 202:1833. PubMed
  95. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  96. Chanda MK, et al. 2022. J Immunol Methods. 506:113290. PubMed
  97. Campisi L, et al. 2022. Nature. 606:945. PubMed
  98. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  99. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  100. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  101. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  102. Khaw YM, et al. 2023. EMBO Rep. 24:e54228. PubMed
  103. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  104. Wu Q, et al. 2023. Cell Rep. 42:112057. PubMed
  105. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  106. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  107. Liu S, et al. 2020. Neuron. S0896-6273(20)30532-8.. PubMed
  108. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  109. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  110. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  111. Zhou L, et al. 2021. Cell Mol Immunol. 18:698. PubMed
  112. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  113. Hu Z, et al. 2015. J Exp Med. 101084/jm20150178. PubMed
  114. Palumbo R, et al. 2012. J Control Release. 159:232. PubMed
  115. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  116. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  117. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  118. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  119. Mori T, et al. 2014. J Immunol. 193:1728. PubMed
  120. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  121. Stone MB et al. 2017. eLife. 6 pii: e19891. PubMed
  122. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  123. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  124. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  125. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  126. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  127. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  128. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  129. Khaw YM, et al. 2020. J Neuroinflammation. 17:49. PubMed
  130. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  131. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  132. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  133. Köchl R, et al. 2020. Elife. 9:00. PubMed
  134. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  135. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  136. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  137. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  138. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  139. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  140. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  141. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  142. Yang Z et al. 2016. eLife. 5 pii: e21238. PubMed
  143. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  144. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  145. Lei G, et al. 2015. Infect Immun . 83:572. PubMed
  146. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  147. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  148. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  149. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  150. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  151. Jawhara S, et al. 2012. J Immunol. 189:2468. PubMed
  152. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  153. Cheng Q, et al. 2014. J Immunol. 192:3686. PubMed
  154. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  155. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  156. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  157. Baptista A, et al. 2014. Elife. 3:4433. PubMed
  158. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  159. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  160. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  161. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  162. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  163. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  164. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  165. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  166. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  167. Hu G, et al. 2018. Immunity. 48:227. PubMed
  168. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  169. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  170. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  171. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  172. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  173. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  174. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  175. Zhu J et al. 2017. Cell stem cell. 20(3):374-384 . PubMed
  176. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  177. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  178. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  179. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  180. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  181. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  182. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
RRID
AB_313773 (BioLegend Cat. No. 117304)
AB_313772 (BioLegend Cat. No. 117303)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
PE/Fire™ 640 anti-mouse CD11c Antibody N418 FC
APC/Fire™ 810 anti-mouse CD11c Antibody N418 FC
Spark PLUS B550™ anti-mouse CD11c N418 FC
Spark PLUS V475™ anti-mouse CD11c Antibody N418 FC
Spark YG™ 581 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark YG™ 593 anti-mouse CD11c (Flexi-Fluor™) Antibody N418 FC
Go To Top Version: 4    Revision Date: 01-26-2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account